Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. EJSO 2017; 43: 672-679.

Published: 5th January 2018

Authors: Sávolt A, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E et al.

Conclusion

Median follow-up was 97 months in this study that included 474 women. Axillary recurrence occurred in 2 per cent after axillary dissection and 1.7 per cent after axillary radiotherapy (P=1.00). Disease-free survival (72.1 vs 77.4 per cent, respectively) and overall survival rates (77.9 vs 84.8 per cent) were also similar.

Pubmed Link

Your comments

0 Comments